Both PON1 Q192R and CYP2C19*2 influence platelet response to clopidogrel and ischemic events in Chinese patients undergoing percutaneous coronary intervention

about

Haplotype of platelet receptor P2RY12 gene is associated with residual clopidogrel on-treatment platelet reactivity Effect of cytochrome P450 2C19*17 allelic variant on cardiovascular and cerebrovascular outcomes in clopidogrel-treated patients: A systematic review and meta-analysis.

P2860

Q37602843-A2BDEF44-F326-4642-A023-49F0527FCD1C Q42276271-3D739740-BB67-4558-90FB-37C4D251A964

P2860

Both PON1 Q192R and CYP2C19*2 influence platelet response to clopidogrel and ischemic events in Chinese patients undergoing percutaneous coronary intervention

Item

http://www.wikidata.org/entity/Q35959359

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Both PON1 Q192R and CYP2C19*2 ...... utaneous coronary intervention

@ast

Both PON1 Q192R and CYP2C19*2 ...... utaneous coronary intervention

@en

type

Item

label

Both PON1 Q192R and CYP2C19*2 ...... utaneous coronary intervention

@ast

Both PON1 Q192R and CYP2C19*2 ...... utaneous coronary intervention

@en

prefLabel

Both PON1 Q192R and CYP2C19*2 ...... utaneous coronary intervention

@ast

Both PON1 Q192R and CYP2C19*2 ...... utaneous coronary intervention

@en

P1476

Both PON1 Q192R and CYP2C19*2 ...... utaneous coronary intervention

@en

P2093

Xiaohong Huang

http://www.w3.org/2001/XMLSchema#string

Yachen Zhang

http://www.w3.org/2001/XMLSchema#string

Yong Tang

http://www.w3.org/2001/XMLSchema#string

Yu Chen

http://www.w3.org/2001/XMLSchema#string

Yuquan Xie

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement

Clopidogrel resistance?

Platelet glycoprotein IIb/IIIa polymorphism and coronary artery disease: implications for clinical practice

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?

Paraoxonase-1 is not a major determinant of stent thrombosis in a Taiwanese population

Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography

Cytochrome p-450 polymorphisms and response to clopidogrel.

Paraoxonase 1 (PON1) gene variants are not associated with clopidogrel response.

Genetic causes of clopidogrel nonresponsiveness: which ones really count?

P304

9266-9274

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26309584

http://www.w3.org/2001/XMLSchema#string

P921

clopidogrel

P932

4538118

http://www.w3.org/2001/XMLSchema#string

Both PON1 Q192R and CYP2C19*2 influence platelet response to clopidogrel and ischemic events in Chinese patients undergoing percutaneous coronary intervention

about

P2860

P2860

Both PON1 Q192R and CYP2C19*2 influence platelet response to clopidogrel and ischemic events in Chinese patients undergoing percutaneous coronary intervention

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932